News | January 11, 2022
Prof. Jason Kovacic bags Agilent Thought Leader award
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
This unique record was made possible by collating hard copies of the books in a structured manner
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
It is the first-ever fully remote end-to-end Remote Patient Monitoring (RPM) service to include cardiac arrhythmia analysis in a single, intuitive platform
The agreement follows positive NICE recommendation and commits to deliver Leqvio (inclisiran) access via a population health management approach identifying eligible patients across England
It measures 9 French (3 millimetres) in diameter upon insertion and removal from the body. While in the heart, it expands to support the heart’s pumping function, providing flow greater than 3.5 L/min
Subscribe To Our Newsletter & Stay Updated
